Literature DB >> 24468688

Lower urinary tract symptoms in a 66-year-old man.

Dean S Elterman, Steven A Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24468688      PMCID： PMC3986315          DOI： 10.1503/cmaj.130449

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

Review 2.  Optimising the medical management of benign prostatic hyperplasia.

Authors:  Michael Marberger; Richard Harkaway; Jean de la Rosette
Journal:  Eur Urol       Date:  2004-04       Impact factor: 20.096

3.  2010 Update: Guidelines for the management of benign prostatic hyperplasia.

Authors:  J Curtis Nickel; Carlos E Méndez-Probst; Thomas F Whelan; Ryan F Paterson; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

4.  Update on AUA guideline on the management of benign prostatic hyperplasia.

Authors:  Kevin T McVary; Claus G Roehrborn; Andrew L Avins; Michael J Barry; Reginald C Bruskewitz; Robert F Donnell; Harris E Foster; Chris M Gonzalez; Steven A Kaplan; David F Penson; James C Ulchaker; John T Wei
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

Review 5.  Serenoa repens for benign prostatic hyperplasia.

Authors:  James Tacklind; Roderick Macdonald; Indy Rutks; Judith U Stanke; Timothy J Wilt
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 6.  Role of 5α-reductase inhibitors in benign prostatic diseases.

Authors:  F Azzouni; J Mohler
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-02-14       Impact factor: 5.554

Review 7.  Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on alpha-adrenoceptor antagonists.

Authors:  Shirin Milani; Bob Djavan
Journal:  BJU Int       Date:  2005-06       Impact factor: 5.588

8.  Evaluation and treatment of lower urinary tract symptoms in older men.

Authors:  P Abrams; C Chapple; S Khoury; C Roehrborn; J de la Rosette
Journal:  J Urol       Date:  2009-02-23       Impact factor: 7.450

Review 9.  Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: the best of both worlds.

Authors:  Peter Wong; Nathan Lawrentschuk; Damien M Bolton
Journal:  Curr Opin Urol       Date:  2009-01       Impact factor: 2.309

10.  Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study.

Authors:  Paul Toren; David Margel; Girish Kulkarni; Antonio Finelli; Alexandre Zlotta; Neil Fleshner
Journal:  BMJ       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.